» Articles » PMID: 32446876

Reduced Somatostatin Signalling Leads to Hypersecretion of Glucagon in Mice Fed a High-fat Diet

Overview
Journal Mol Metab
Specialty Cell Biology
Date 2020 May 25
PMID 32446876
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Elevated plasma glucagon is an early symptom of diabetes, occurring in subjects with impaired glucose regulation. Here, we explored alpha-cell function in female mice fed a high-fat diet (HFD).

Methods: Female mice expressing the Ca indicator GCaMP3 specifically in alpha-cells were fed a high-fat or control (CTL) diet. We then conducted in vivo phenotyping of these mice, as well as experiments on isolated (ex vivo) islets and in the in situ perfused pancreas.

Results: In HFD-fed mice, fed plasma glucagon levels were increased and glucagon secretion from isolated islets and in the perfused mouse pancreas was also elevated. In mice fed a CTL diet, increasing glucose reduced intracellular Ca ([Ca]) oscillation frequency and amplitude. This effect was also observed in HFD mice; however, both the frequency and amplitude of the [Ca] oscillations were higher than those in CTL alpha-cells. Given that alpha-cells are under strong paracrine control from neighbouring somatostatin-secreting delta-cells, we hypothesised that this elevation of alpha-cell output was due to a lack of somatostatin (SST) secretion. Indeed, SST secretion in isolated islets from HFD-fed mice was reduced but exogenous SST also failed to suppress glucagon secretion and [Ca] activity from HFD alpha-cells, in contrast to observations in CTL mice.

Conclusions: These findings suggest that reduced delta-cell function, combined with intrinsic changes in alpha-cells including sensitivity to somatostatin, accounts for the hyperglucagonaemia in mice fed a HFD.

Citing Articles

Somatostatin triggers local cAMP and Ca signaling in primary cilia to modulate pancreatic β-cell function.

Nilsson C, Dumral O, Sanchez G, Xie B, Muller A, Solimena M EMBO J. 2025; .

PMID: 39939781 DOI: 10.1038/s44318-025-00383-7.


Real-time detection of somatostatin release from single islets reveals hypersecretion in type 2 diabetes.

Yang M, Mandal K, Sodergren M, Dumral O, Winroth L, Tengholm A Acta Physiol (Oxf). 2025; 241(2):e14268.

PMID: 39803760 PMC: 11726413. DOI: 10.1111/apha.14268.


Heterogeneous endocrine cell composition defines human islet functional phenotypes.

Evans-Molina C, Pettway Y, Saunders D, Sharp S, Bate T, Sun H bioRxiv. 2024; .

PMID: 39605606 PMC: 11601672. DOI: 10.1101/2024.11.20.623809.


Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells.

Ruiz-Pino A, Goncalves-Ramirez A, Jimenez-Palomares M, Merino B, Castellano-Munoz M, Vettorazzi J Pflugers Arch. 2024; 477(2):207-221.

PMID: 39601887 DOI: 10.1007/s00424-024-03045-5.


Alterations in Glucagon Levels and the Glucagon-to-Insulin Ratio in Response to High Dietary Fat or Protein Intake in Healthy Lean Adult Twins: A Post Hoc Analysis.

Schuppelius B, Schuler R, Pivovarova-Ramich O, Hornemann S, Busjahn A, Machann J Nutrients. 2024; 16(22).

PMID: 39599691 PMC: 11597242. DOI: 10.3390/nu16223905.


References
1.
Vergari E, Denwood G, Salehi A, Zhang Q, Adam J, Alrifaiy A . Somatostatin secretion by Na-dependent Ca-induced Ca release in pancreatic delta-cells. Nat Metab. 2020; 2(1):32-40. PMC: 6986923. DOI: 10.1038/s42255-019-0158-0. View

2.
Hughes J, Ustione A, Lavagnino Z, Piston D . Regulation of islet glucagon secretion: Beyond calcium. Diabetes Obes Metab. 2018; 20 Suppl 2:127-136. PMC: 6148361. DOI: 10.1111/dom.13381. View

3.
Yu Q, Shuai H, Ahooghalandari P, Gylfe E, Tengholm A . Glucose controls glucagon secretion by directly modulating cAMP in alpha cells. Diabetologia. 2019; 62(7):1212-1224. PMC: 6560012. DOI: 10.1007/s00125-019-4857-6. View

4.
Unger R, Cherrington A . Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest. 2012; 122(1):4-12. PMC: 3248306. DOI: 10.1172/JCI60016. View

5.
Babinsky V, Hannan F, Ramracheya R, Zhang Q, Nesbit M, Hugill A . Mutant Mice With Calcium-Sensing Receptor Activation Have Hyperglycemia That Is Rectified by Calcilytic Therapy. Endocrinology. 2017; 158(8):2486-2502. PMC: 5551547. DOI: 10.1210/en.2017-00111. View